PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 75 filers reported holding PASSAGE BIO INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $125 | -15.0% | 130,188 | +21.9% | 0.01% | -33.3% |
Q4 2022 | $147 | -99.9% | 106,836 | +25.4% | 0.02% | +28.6% |
Q3 2022 | $106,000 | -50.0% | 85,196 | -5.0% | 0.01% | -56.2% |
Q2 2022 | $212,000 | +0.5% | 89,704 | +31.8% | 0.03% | +14.3% |
Q1 2022 | $211,000 | +43.5% | 68,039 | +194.7% | 0.03% | +55.6% |
Q4 2021 | $147,000 | -32.9% | 23,086 | +5.0% | 0.02% | -18.2% |
Q3 2021 | $219,000 | – | 21,979 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 2,497,922 | $63,872,000 | 14.76% |
FRAZIER MANAGEMENT LLC | 5,009,219 | $128,086,000 | 9.86% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 602,248 | $15,399,000 | 7.53% |
Vivo Capital, LLC | 1,487,038 | $38,024,000 | 1.70% |
Boxer Capital, LLC | 1,928,315 | $49,307,000 | 1.58% |
Orbimed Advisors | 6,962,899 | $178,041,000 | 1.56% |
Logos Global Management LP | 344,438 | $8,807,000 | 0.76% |
EMERALD ADVISERS, LLC | 340,698 | $8,712,000 | 0.29% |
Ikarian Capital, LLC | 136,697 | $3,495,000 | 0.15% |
Weiss Multi-Strategy Advisers LLC | 300,554 | $7,685,000 | 0.15% |